To determine whether patients should participate directly in detecting adverse reactions to drugs their ability to provide written reports of symptoms experienced during treatment with amoxycillin or
Introduction
Although there have been many attempts to improve the postmarketing surveillance of drugs,'`patients have participated directly in only a few of them.6`9 An extensive centralised monitoring system based on written reports from patients would be cheap and might lead to quicker identification of symptomatic reactions to some new drugs. Such a system would have to be evaluated thoroughly before implementation on any scale. We conducted a pilot study to investigate the reliability and validity of patients' reporting. We compared the responses of patients who were asked to report all events experienced during antibiotic treatment with those of patients who were asked to report only what they thought were reactions to the drugs. We also compared patients' perceptions of adverse reactions with those of a panel of experts.
Patients and methods
The study methods were approved by the regional research ethics committee. We used two types of questionnaire-namely, a reaction report form and the reaction report form combined with an event report form. Community pharmacists were provided with equal numbers of each type arranged in random sequence, and they were asked to distribute them in the predetermined order and after obtaining informed consent to consecutive patients presenting prescriptions for amoxycillin or trimethoprimsulphamethoxazole. The pharmacists were instructed to present the forms to patients as "a survey of the health of people who have to take medicines." They were given no specific advice on counselling patients about adverse drug reactions. Pharmacists made a note of the name and telephone number of all participants and the date of dispensing. Parents completed forms on behalf of children under 12 years old.
The reaction report form, which was given to all patients, requested information on sex and age, why the antibiotic had been prescribed, and whether the drug had been used before. It was a simple version of the type of report card distributed by many national monitoring centres for use by doctors and other health professionals. It invited patients to report anything that they thought was a reaction to their antibiotic during one week of treatment.
The combined forms were arranged with the event report form on the front, which patients were asked to complete first. In the event report form patients were asked to agree or disagree with 33 statements about any disorders of or changes in body systems and senses during the week of treatment. Other than directing patients to parts of the body or systems the statements were open ended-for example, "in the past week there has been something wrong with my skin" or "in the past week there has been a change in my mood." Statements contained in the event report form overlapped slightly to maximise the chance of detecting events in different systems. For the purpose of analysis these statements were combined into 19 symptom groups-for instance, ears and hearing were combined as were eyes and eyesight. We also included statements about the heart and liver. We recognised that patients might not accurately attribute symptoms to abnormalities in these organs, but we wanted to present them with an opportunity to report diagnoses made by others. The patients were asked to describe in their own words the abnormalities or changes that they had identified by agreeing with any of the statements.
Patients returned the forms in prepaid envelopes at the end of one week of treatment. Those patients' and experts' perceptions of adverse reactions the experts evaluated all events elicited in the telephone interviews, judging each to be probably related to treatment or not. We then examined each patient's reaction report to determine which events the patient had identified as adverse reactions. We analysed the level of agreement between patients and experts for each of the 19 symptom groups by means of the x statistic.'0
Finally we compared the performances of the two reporting forms in a hypothetical situation. The experts' views of which events were probably related to the treatment were taken as representing the "truth" about adverse reactions to a new drug. We compared the rates of detecting these "true" reactions with the event report forms (did the patient identify an event in the relevant body system?) and the reaction report forms (did the patient identify a reaction in that body system,?). The performances of the two forms were expressed as sensitivity and specificity."
Results
During February and March 1987, 20 community pharmacists distributed 267 questionnaires to consecutive patients presenting prescriptions for amoxycillin (139) or trimethoprim-sulphamethoxazole (128). Altogether 109 out of 136 reaction report forms and 97 out of 131 combined event report and reaction report forms were returned, giving an overall response rate of 77%. A total of 176 respondents (85%) were interviewed by telephone. Of the 30 patients who could not be interviewed, 11 did not have a telephone, eight had telephones but could not be contacted, and 11 declined to be interviewed. Table I gives the details tWhen not enough events were considered to be drug related x was not calculated. of the patients who were interviewed. In general, patients who received the combined form and those who received only the reaction report form seemed to be similar. Reliability and validity of event report form-The responses contained in 83 completed event report forms were analysed. There were 2654 (97%) responses to 2739 statements; 419 (16%) statements elicited responses indicating an abnormality or change in a body system. The agreement between what was reported in the event report forms and the response to the same statements posed to the same patients during the telephone interviews was 85%. This suggested that the event report forms were reliable (x=0 56). More positive responses were elicited by the supplementary questions during the telephone interviews, and this was reflected in the modest sensitivity of the event report form (54%). Specificity was high (94%) and if an event was noted on the form it was likely to be confirmed at telephone interview (positive predictive value 79%). There was no appreciable difference when the data were analysed by sex and age.
Agreement between patients and expert panel-The agreement between the patients and the panel was assessed from the 1019 clinical events reported during the telephone interviews. Most of the events were related to the patients' illness. Overall the experts thought that more events were related to the treatment than did patients (table II) . This was particularly so in the case of disorders of the skin (itching and rashes) and bowel (diarrhoea). In contrast, patients seemed as likely as the experts to attribute upper gastrointestinal disturbances to the drugs. The overall agreement between patients and panel was high owing to their agreement that most of the events were not related to treatment. As indicated by the x statistic, agreement on whether disorders of the stomach and head and of sleep were related to treatment was fair. Table III gives examples of the calculation of the x statistic.
Comparison ofreaction reporting and event reportingThe event report form had a higher sensitivity than the reaction report form for the adverse reactions when compared with the experts' judgment on the complete sets of events reported (table IV) . By contrast it had a lower specificity and a lower positive predictive value than the reaction report form.
BMJ VOLUME 297 8 OCTOBER 1988 Discussion Our primary interest in this study was whether patients could be persuaded to report their experiences during drug treatment in a reliable and valid way to a group other than those who prescribed the drug for them. The results suggest that patients will comply with such a request, though the response rate of 77% was achieved only after telephone reminders, and this might be impractical in a large study. The study conditions were optimal as patients were mainly young and receiving short term treatment with drugs with known adverse reactions.
Most of the events reported were related to the illness of the patient. This indicates the "noise" that should be expected in a system based on comprehensive reporting of events by patients. The low rate of "true" adverse drug reactions meant that the expected chance agreement between patients and experts that events were not related to treatment was high. This should not obscure the fact that patients were conservative in attributing clinical events to their treatment. Furthermore, as they did not agree with the experts that skin and bowel complaints were related to their treatment this suggests that their responses were not cued by advice given previously by family doctors or pharmacists. This conservatism in reporting reactions is important. A notable limitation of reaction reporting is its low sensitivity for detecting true adverse reactions. The higher sensitivity of event reporting probably shows that this is a better detection system, although the positive predictive value was low, partly because so many of the events were related to the patients' illness. The event rate was high among our patients, who were mostly suffering from acute infections, and it might be lower during monitoring of drugs used to treat other conditions.
Though direct participation of patients in event reporting has been described previously,89 this is one of only two attempts to evaluate patients' reports of adverse reactions. Our data have shown the reliability and validity of written reporting of events. Although we are still not sure of the value of postmarketing surveillance based on patients' reports, we believe that a large scale trial of event reporting initiated by patients is justified. If event report forms were distributed routinely by community pharmacists thousands of reports could be obtained for widely used drugs. The reports would be much more efficiently handled if patients completed forms that could be processed by an automated reading system. If responses were available from patients receiving drugs with similar indications and possibly also from a population not taking any drugs the reports could be screened for clusters of events in particular systems of the body. The lack of detail would prevent much clinical interpretation, but the system would be cheap and might help the early identification of adverse reactions. If a new side effect was observed it could be confirmed or explained by using the conventional national monitoring system for voluntary reports from health professionals.
